05/12/2022 4:15 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2022 4:29 PM | Supernus Pharmaceuticals (Filer)
| Form NT 10-Q
| |
05/09/2022 4:22 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2022 3:42 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/13/2022 3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2021 4:17 PM | DEC TIMOTHY C (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/24/2021 4:13 PM | DEC TIMOTHY C (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/06/2021 11:52 AM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/04/2021 4:28 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2021 3:36 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
06/25/2021 11:30 AM | Supernus Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/25/2021 7:12 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2021 8:04 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/26/2021 3:35 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2021 3:46 PM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/24/2021 3:44 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2021 3:58 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2021 1:34 PM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/30/2021 1:31 PM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/14/2021 7:24 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/30/2021 5:23 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2021 3:30 PM | Supernus Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/24/2021 4:27 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/24/2021 11:48 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2021 5:55 PM | Kelly James Patrick (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:54 PM | Rubin Jonathan (Reporting) Supernus Pharmaceuticals (Issuer) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:54 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:53 PM | Mottola Frank (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:51 PM | Bhatt Padmanabh P. (Reporting) Supernus Pharmaceuticals (Issuer) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:49 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:49 PM | SIEBERT JOHN M (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:49 PM | Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:49 PM | Banyai William (Reporting) Supernus Pharmaceuticals (Issuer) Twist Bioscience Corp (Issuer) Twist Bioscience Corp (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:48 PM | GEMAYEL GEORGES (Reporting) GEMAYEL GEORGES (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:48 PM | Supernus Pharmaceuticals (Issuer) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:47 PM | Hudson Frederick M. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:46 PM | NEWHALL CHARLES W III (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 5:46 PM | Barlow Carrolee (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2021 4:14 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2021 3:50 PM | BlackRock Inc. (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G
| |
01/04/2021 6:59 PM | Rubin Jonathan (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/22/2020 4:49 PM | Schwabe Stefan K.F. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2020 7:20 PM | Schwabe Stefan K.F. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2020 4:27 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/10/2020 3:19 PM | PATRICK GREGORY S (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2020 4:43 PM | PATRICK GREGORY S (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2020 2:31 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/15/2020 5:04 PM | PATRICK GREGORY S (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2020 11:03 AM | Kelly James Patrick (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2020 11:00 AM | Kelly James Patrick (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/14/2020 11:26 AM | Supernus Pharmaceuticals (Filer) Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2020 3:31 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/02/2020 4:12 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2020 3:11 PM | PATRICK GREGORY S (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/24/2020 3:12 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K/A
| |
08/17/2020 3:52 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/11/2020 3:35 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2020 3:13 PM | Supernus Pharmaceuticals (Filer)
| Form NT 10-Q
| |
07/28/2020 3:35 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2020 2:18 PM | Supernus Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2020 4:13 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2020 7:07 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/27/2020 3:33 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2020 5:59 PM | PATRICK GREGORY S (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/12/2020 1:14 PM | Supernus Pharmaceuticals (Filer)
| Form NT 10-Q
| |
05/11/2020 5:42 PM | PATRICK GREGORY S (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2020 3:52 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2020 11:00 AM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/24/2020 8:27 AM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/24/2020 8:26 AM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/23/2020 7:36 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2020 4:13 PM | ARMISTICE CAPITAL, LLC (Filed by) Supernus Pharmaceuticals (Subject)
| Form SC 13G
| |
02/28/2020 12:05 PM | Supernus Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/25/2020 5:51 PM | Mottola Frank (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/25/2020 5:40 PM | Mottola Frank (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/25/2020 5:33 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/25/2020 5:31 PM | Martin Tami Tillotson (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/25/2020 4:59 PM | NEWHALL CHARLES W III (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2020 3:36 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2020 10:07 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2019 3:02 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2019 3:12 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2019 1:59 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019 4:14 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2019 3:04 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2019 3:29 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/27/2019 4:27 PM | Khattar Jack A. (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2019 11:25 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2019 10:02 AM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019 3:57 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2019 4:28 PM | PATRICK GREGORY S (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/23/2019 4:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2019 7:06 PM | SIEBERT JOHN M (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2019 3:29 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2019 3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2019 2:38 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2019 4:30 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2019 3:12 PM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/29/2019 2:43 PM | SIEBERT JOHN M (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2019 4:33 PM | Matushansky Igor (Reporting) Supernus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |